For consumers
(1300 633 424)
Mon-Fri | 9am-5pm AEST
Your call will be answered by healthdirect Australia
For health professionals
Find out the active ingredient and other brand names of your medicines with the NPS Medicine Name Finder
For a medicinewise Australia
Independent. Not-for-profit. Evidence based.

Date published: April 2007
WARNING
Since this issue of Medicine Update was published, Prexige (lumiracoxib) has been urgently withdrawn by the Therapeutic Goods Administration because of a small number of cases of serious liver side effects. Prexige is no longer available in Australia.
If you take Prexige, stop taking it immediately and see your doctor to discuss an alternative to this drug and to arrange any tests you may need. If you cannot see your doctor, talk to your pharmacist, or ring the Therapeutic Goods Administration (TGA) info line on 1800 004 599, Novartis Pharmaceuticals on 1800 671 203, or NPS Medicines Line on 1300 888 763.
To find out more about the withdrawal of Prexige in Australia:
Risks and benefits differ between medicines and from person to person.
Your doctor can help you compare different medicines and treatments to decide what is best for your particular situation.
When you are considering a new medicine it is important to find out how it compares with other treatments. To do this you need to weigh up the expected benefits and the possible risks of the new medicine, compared with other available medicines or treatments.
Sometimes new medicines have benefits like:
The risks of new medicines can include:
The active ingredient is the chemical in the medicine that makes the medicine work.
Lumiracoxib (pronounced ‘loo – MEE – rah – cox – ib’)
Brand name: ‘Prexige’
Active ingredient: lumiracoxib
Lumiracoxib is a type of medicine called an NSAID (pronounced ‘en-sed’). ‘NSAID’ stands for ‘non-steroidal anti-inflammatory drug’. NSAIDs are also known as 'antiinflammatories’.
Lumiracoxib reduces pain and inflammation.
It is available under the Pharmaceutical Benefits Scheme (PBS) to treat osteoarthritis.
Talk with your doctor about all of the treatment options for osteoarthritis.
If you are thinking about using an NSAID (non-steroidal anti-inflammatory drug) for your osteoarthritis for the first time, or you are already taking an NSAID, then lumiracoxib is one of several options.
Other NSAIDs available in Australia include:
These other NSAIDs also reduce pain and inflammation and are used to relieve joint and muscle pain from arthritis, backache and sprains. Some are used to treat headaches, period pain and minor injuries.
This review only compares lumiracoxib with other NSAIDs. Other medicines that are used for osteoarthritis include paracetamol and glucosamine – these may be recommended instead of, or as well as, NSAIDs.
Lumiracoxib has been compared in clinical trials with three other NSAIDs — diclofenac, celecoxib and ibuprofen — for osteoarthritis. The trials compared the pain and stiffness experienced by people taking lumiracoxib with that experienced by people taking the other NSAIDs. They also looked at whether lumiracoxib improved mobility.
The results found that lumiracoxib is no better or worse at reducing pain and stiffness, or improving mobility in people with osteoarthritis than these other NSAIDs.
This research suggests that lumiracoxib does not seem to be any more effective than other NSAIDs. However, you may find that one NSAID works better for you than other NSAIDs.
For a complete list of possible side effects, see the consumer medicine information
(CMI) for lumiracoxib (see section 11 for details).
Talk to your doctor about the possible side effects of this medicine before you use it.
All medicines can have side effects. Sometimes the side effects are serious but most of the time they are not.
The serious side effects to consider when deciding whether to use lumiracoxib – or any other NSAID – are heart and stomach problems.
Your doctor can assess your individual risk of getting heart and circulation problems and whether this prevents you from taking an NSAID.
Your doctor can assess your individual risk of developing stomach problems and whether this prevents you from taking an NSAID.
Heart and circulation problems
People taking NSAIDs long-term appear to have a higher risk of heart attack and stroke than people who do not use NSAIDs. The number of people who will experience a heart attack with NSAIDs in the general population is very small.
However if you already have a high risk of heart or circulation problems, you should avoid using any NSAID — including lumiracoxib — if possible. Using an NSAID may increase your risk of heart and circulation problems further.
Factors that may put you at risk of heart and circulation problems
You may have a higher risk of heart and circulation problems if you:
If you think any of these risk factors apply to you, you should discuss this information with your doctor.
Stomach problems
All NSAIDs, including lumiracoxib, can cause seriousstomach problems. However, some NSAIDs are more likely to cause stomach problems than others.
For most people, the risk of serious stomach problems is the same whether they take lumiracoxib or another NSAID.
However, if you have a high risk of developing serious stomach problems with an NSAID, you should avoid using any NSAID— including lumiracoxib — if possible. If this is not possible, choose an NSAID that is less likely to cause stomach problems.
– you have a 12 in 1000 chance of developing a serious stomach problem if you take lumiracoxib for a year, compared to a 44 in 1000 chance with ibuprofen or naproxen
but if you are taking aspirin as well as lumiracoxib,the risk of serious stomach problems is the same aswith ibuprofen or naproxen, because aspirin can also cause serious stomach problems.
– you have a 3 in 1000 chance of developing a serious stomach problem if you take lumiracoxib for a year, compared to an 11 in 1000 chance with ibuprofen or naproxen.
Factors that may put you at risk of stomach problems
You may be at high risk of developing serious stomach problems with NSAIDs if you:
Having one of these factors can increase the risk of a serious stomach problem by two to four times.
If you think any of these risk factors apply to you, you should discuss this information with your doctor.
Always tell your doctor about any changes to your condition if you are taking a new medicine.
Use NSAIDs only when you need them, rather than every day, to reduce your risk of side effects.
Use the lowest dose that controls your pain, and talk to your doctor about other ways to manage your pain. For example, you may be able to manage your pain with regular doses of paracetamol, and only use an NSAID for extra pain relief when needed — such as when carrying out activities that usually increase your pain, e.g. exercise.
Sometimes, less common side effects do not become obvious until large numbers of people have used the medicine.
Prescription medicines go through many tests and clinical trials before they can be prescribed in Australia. All medicines go through four types of tests for their effectiveness, side effects and safety:
The Therapeutic Goods Administration (Australia’s regulatory agency for medicines) checks these results before it approves the registration of the medicine for use in Australia.
Medicines are made available on the PBS if they are shown to be as good or better than other available medicines for the same condition.
Most medicines prescribed by your doctor are covered by the PBS. This means that the Australian government pays part of the cost of your medicine.
You will need to pay the full price if the medicine is not available on the PBS, or is not available on the PBS for your specific condition.
Lumiracoxib became available on the Pharmaceutical Benefit Scheme (PBS) from 1 August 2006 (200 mg dose only).
This medicine can only be prescribed on the PBS for people with osteoarthritis.
If you have osteoarthritis and are eligible for the PBS, the cost you will pay is the ‘PBS co-payment’, set by the Australian government. In January 2007, the co-payment was:
The cost to the government for each lumiracoxib prescription is $29.91, however people without a concession card still pay $30.70 because of pharmacy fees.
Lumiracoxib has also been shown to relieve period pain and pain caused by joint or dental surgery, however it is not available on the PBS for these uses. Speak to your doctor if you have any of these conditions and believe lumiracoxib may be suitable for you.
CMIs are available for most prescription medicines.
Read the consumer medicine information (CMI) leaflet
Before you start taking a new medicine, you should read the Consumer Medicine Information (CMI). The CMI will tell you:
You can get the CMI for lumiracoxib from:
Speak to your doctor about what exercise program or treatment might be suitable for you.
To find out more about ‘osteoarthritis’ call Arthritis Australia on 1800 111 101 (free call
in Australia).
Even if you are taking medicines there are other things you can do to help your osteoarthritis.
It is important to stay active if you have osteoarthritis. Regular exercise will help to:
You may find that medicines do not relieve pain completely. There are other things you can do to help relieve pain:
Read the consumer medicine information (CMI) leaflet for this medicine. The CMI will tell you:
You can get the CMI leaflet for Prexige from:
Call the Adverse Medicine Events (AME) Line on 1300 134 237 (Mon–Fri, 9am–5pm EST).
The AME Line lets you report and discuss side effects that might be related to your medicine. The side effects of your medicine — but not your personal details — are reported to the Australian medicines regulatory agency (the Therapeutic Goods Administration or TGA for short). The information helps to improve the safe use of medicines.
See AME Line for more information.
See About Medicine Update for more information about this publication.
Date published: 2007-04-01 00:00:00
Reasonable care is taken to provide accurate information at the date of creation. This information is not intended as a substitute for medical advice from a qualified health professional. Health professionals should rely on their own expertise and enquiries when providing medical advice or treatment. Where permitted by law, NPS disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer.
References to brands should not be taken as an endorsement by NPS.